CMS postpones final price transparency rule | Senators fail to obtain unanimous consent on drug pricing bills | FDA seeks input on postmarket drug safety surveillance
November 8, 2019
FOLLOW PCMA ON TWITTER  Twitter
PCMA SmartBrief
News for the PBM Industry
SIGN UP ⋅   FORWARD ⋅   ARCHIVE
Featured Story
CMS postpones final price transparency rule
The CMS is postponing finalization of a proposed rule that would require hospitals to publish insurer-negotiated rates for health care services, and Administrator Seema Verma indicated in a tweet that the rule will be released along with a comprehensive proposal for health plan transparency. The agency said it received over 1,400 comments on the proposal.
Healthcare Finance (11/7) 
LinkedIn Twitter Facebook Email
Legislative & Regulatory News
Senators fail to obtain unanimous consent on drug pricing bills
A spokesman for Sen. John Cornyn, R-Texas, said he plans to try again next week to obtain unanimous consent on legislation that would restrict efforts by drugmakers to delay competition from generic drugs. Sens. Chuck Grassley, R-Iowa, and Dick Durbin, D-Ill., also failed in their attempt to pass by unanimous consent a measure that would require drug companies to disclose prices in television ads.
The Hill (11/7) 
LinkedIn Twitter Facebook Email
FDA seeks input on postmarket drug safety surveillance
The FDA is seeking public comment on its draft version of best practices for postmarket safety surveillance of drugs and biologics. The draft discusses surveillance for different product types, as well as specific patient populations, identification of safety signals and possible agency actions.
Regulatory Focus (11/6) 
LinkedIn Twitter Facebook Email
Drug Industry Spotlight
US sues Gilead over patents related to HIV drug
US sues Gilead over patents related to HIV drug
(Denis Charlet/AFP via Getty Images)
The US government has filed a lawsuit against Gilead Sciences for allegedly infringing government-owned patents related to the company's HIV drug Truvada. Gilead donated Truvada to the government for testing purposes, and the CDC determined it could be used to prevent infection. It has received several patents for treatment regimens it developed using Truvada.
HuffPost (11/7) 
LinkedIn Twitter Facebook Email
 
Opinion, Commentary & Analysis
PBMs work for low costs, high quality
Pharmacy benefit managers negotiate with drugmakers to obtain the best possible prices for patients, taxpayers and employers and pass along savings to health insurance plans so they can keep premiums and copays low, writes PCMA CEO JC Scott. Moreover, PBMs provide innovative tools that improve patient care and health, Scott writes.
The Examiner (Washington, D.C.) (11/8) 
LinkedIn Twitter Facebook Email
N.Y. legislation would undermine efforts to control health spending
Certain provisions in legislation bound for New York Gov. Andrew Cuomo's desk would be "counterproductive to the state's efforts to rein in health care costs and should be removed from the potential law," writes Heather Briccetti, president and CEO of the Business Council of New York.
The Buffalo News (N.Y.) (tiered subscription model) (11/7) 
LinkedIn Twitter Facebook Email
  
  
Where there is age there is evolution, where there is life there is growth.
Anjelica Huston,
actress, director, producer
LinkedIn Twitter Facebook Email
  
  
Learn more about PCMA:
Upcoming PCMA Events | PCMA Newsroom
Become a PCMA Affiliate
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 270 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

Contact PCMA
Charles Cote
Vice President, Strategic Communications
Sign Up
SmartBrief offers 200+ newsletters
Subscriber Tools:
Contact Us:
Editor  -  Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2019 SmartBrief, Inc.®
Privacy Policy (updated May 25, 2018) |  Legal Information